CZ20011764A3 - Činidla interagující s draslíkovým kanálem a jejich pouľití - Google Patents

Činidla interagující s draslíkovým kanálem a jejich pouľití

Info

Publication number
CZ20011764A3
CZ20011764A3 CZ20011764A CZ20011764A CZ20011764A3 CZ 20011764 A3 CZ20011764 A3 CZ 20011764A3 CZ 20011764 A CZ20011764 A CZ 20011764A CZ 20011764 A CZ20011764 A CZ 20011764A CZ 20011764 A3 CZ20011764 A3 CZ 20011764A3
Authority
CZ
Czechia
Prior art keywords
potassium channel
agent interacting
interacting
agent
potassium
Prior art date
Application number
CZ20011764A
Other languages
Czech (cs)
English (en)
Inventor
Kenneth Rhodes
Maria Betty
Huai-Ping Ling
Wenquian An
Original Assignee
Millennium Pharmaceuticals, Inc.
American Home Products Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/298,731 external-priority patent/US6369197B1/en
Priority claimed from US09/350,874 external-priority patent/US20020019020A1/en
Priority claimed from US09/399,913 external-priority patent/US6361971B1/en
Priority claimed from US09/400,492 external-priority patent/US7115381B1/en
Application filed by Millennium Pharmaceuticals, Inc., American Home Products Corporation filed Critical Millennium Pharmaceuticals, Inc.
Publication of CZ20011764A3 publication Critical patent/CZ20011764A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CZ20011764A 1998-11-20 1999-11-19 Činidla interagující s draslíkovým kanálem a jejich pouľití CZ20011764A3 (cs)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US10933398P 1998-11-20 1998-11-20
US11003398P 1998-11-25 1998-11-25
US11027798P 1998-11-30 1998-11-30
US09/298,731 US6369197B1 (en) 1998-11-20 1999-04-23 Potassium channel interactors and uses therefor
US09/350,874 US20020019020A1 (en) 1998-11-20 1999-07-09 Methods for treating cardiovascular disorders
US09/350,614 US6689581B1 (en) 1998-11-20 1999-07-09 Potassium channel interactors and uses therefor
US09/399,913 US6361971B1 (en) 1998-11-20 1999-09-21 Nucleic acid molecules encoding potassium channel interactors and uses therefor
US09/400,492 US7115381B1 (en) 1998-11-20 1999-09-21 Methods for treating cardiovascular disorders

Publications (1)

Publication Number Publication Date
CZ20011764A3 true CZ20011764A3 (cs) 2002-01-16

Family

ID=27574798

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20011764A CZ20011764A3 (cs) 1998-11-20 1999-11-19 Činidla interagující s draslíkovým kanálem a jejich pouľití

Country Status (12)

Country Link
EP (1) EP1131349A2 (fr)
JP (1) JP2002530104A (fr)
CN (1) CN1346368A (fr)
AU (1) AU775713B2 (fr)
BR (1) BR9915513A (fr)
CA (1) CA2351365A1 (fr)
CZ (1) CZ20011764A3 (fr)
IL (1) IL143148A0 (fr)
MX (1) MXPA01004903A (fr)
NO (1) NO20012471L (fr)
NZ (1) NZ512332A (fr)
WO (1) WO2000031133A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078481B1 (en) 1998-11-20 2006-07-18 Wyeth Potassium channel interactors and uses therefor
US6369197B1 (en) 1998-11-20 2002-04-09 Millennium Pharmaceuticals, Inc. Potassium channel interactors and uses therefor
AU2001296393A1 (en) * 2000-09-27 2002-04-08 Millennium Pharmaceuticals, Inc Potassium channel interactors and uses therefor
EP2353014A2 (fr) * 2008-11-06 2011-08-10 Basf Se Test de criblage ea pour insecticides
GB201906482D0 (en) * 2019-05-08 2019-06-19 Evox Therapeutics Ltd Exosome comprising stabilized RNA therapeutics

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998016185A2 (fr) * 1996-10-17 1998-04-23 Nps Pharmaceuticals, Inc. Composes bloquants a canal potassium et leur utilisation
US6117989A (en) * 1998-03-26 2000-09-12 Incyte Pharmaceuticals, Inc. Human calcium-binding proteins

Also Published As

Publication number Publication date
NO20012471D0 (no) 2001-05-18
CN1346368A (zh) 2002-04-24
IL143148A0 (en) 2002-04-21
WO2000031133A3 (fr) 2000-10-05
NO20012471L (no) 2001-07-18
BR9915513A (pt) 2002-02-05
EP1131349A2 (fr) 2001-09-12
AU775713B2 (en) 2004-08-12
WO2000031133A2 (fr) 2000-06-02
MXPA01004903A (es) 2003-03-10
JP2002530104A (ja) 2002-09-17
CA2351365A1 (fr) 2000-06-02
NZ512332A (en) 2004-02-27
AU1479700A (en) 2000-06-13

Similar Documents

Publication Publication Date Title
HU9900592D0 (en) Compound and its use
IL183948A (en) Peg-urate oxidase conjugates and use thereof
HUP0104270A3 (en) Herbicidal composition and use thereof
HU9903361D0 (en) Filter-device with collecting-vessel and with heating-device
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
GB9813271D0 (en) Composition and use
ZA200101933B (en) Novel composition and use
GB9817235D0 (en) Compound,composition and use
HUP0103636A3 (en) 2-methyl-thieno-benzodiazepine formulation and its use
EP1056455A4 (fr) Compose d'epimorphine et utilisation de ce dernier
HUP0103473A3 (en) Phosphoglycolipid and methods for its use
PL332616A1 (en) Hydoxymethylhexanones as odorising and savourising agents
GB9817236D0 (en) Compound,composition and use
GB9803232D0 (en) Compound composition and use
CZ20011764A3 (cs) Činidla interagující s draslíkovým kanálem a jejich pouľití
HUP0104723A3 (en) New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use
GB0100361D0 (en) Compound, composition and use
SG80037A1 (en) Potassium channel drugs and their uses
PL336920A1 (en) Guiding and locating member
GB9805172D0 (en) Composition and use
GB9826830D0 (en) Potassium channel activators and their use
GB9911606D0 (en) Composition and use
EP1077705A4 (fr) Agonistes du canal potassium
EP1066051A4 (fr) Scielline et utilisations de celle-ci
PL324932A1 (en) Mould-killing agent